Growing community of inventors

Shanghai, China

Wan He

Average Co-Inventor Count = 8.61

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Wan HeFusheng Zhou (3 patents)Wan HeKai Zhang (2 patents)Wan HeJiong Lan (2 patents)Wan HeYang Liu (2 patents)Wan HeJing Xie (2 patents)Wan HeXiang Chen (2 patents)Wan HeDong Huang (2 patents)Wan HeShuchun Guo (2 patents)Wan HeJinzhu Zhao (2 patents)Wan HeChangjiang Qiao (2 patents)Wan HeTao Jiang (1 patent)Wan HeJiong Lan (1 patent)Wan HeLijian Cai (1 patent)Wan HeChonglan Lin (1 patent)Wan HeXi Chen (0 patent)Wan HeJiong Lan (0 patent)Wan HeKai Zhang (0 patent)Wan HeWan He (3 patents)Fusheng ZhouFusheng Zhou (12 patents)Kai ZhangKai Zhang (86 patents)Jiong LanJiong Lan (34 patents)Yang LiuYang Liu (25 patents)Jing XieJing Xie (23 patents)Xiang ChenXiang Chen (16 patents)Dong HuangDong Huang (9 patents)Shuchun GuoShuchun Guo (6 patents)Jinzhu ZhaoJinzhu Zhao (5 patents)Changjiang QiaoChangjiang Qiao (2 patents)Tao JiangTao Jiang (30 patents)Jiong LanJiong Lan (2 patents)Lijian CaiLijian Cai (1 patent)Chonglan LinChonglan Lin (1 patent)Xi ChenXi Chen (0 patent)Jiong LanJiong Lan (0 patent)Kai ZhangKai Zhang (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Yangtze River Pharmaceutical Group Co., Ltd. (2 from 26 patents)

2. Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (2 from 20 patents)

3. Genfleet Therapeutics (shanghai) Inc. (1 from 5 patents)

4. Zhejiang Genfleet Therapeutics Co., Ltd. (1 from 2 patents)

5. Genfleet Therapeutics Inc. (0 patent)


3 patents:

1. 12054497 - Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereof

2. 11174254 - Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative and use thereof

3. 11155546 - 4,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/3/2025
Loading…